| All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving. | |
| | |
MedLine Citation:
|
PMID: 20945262 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Much attention has been focused in recent years on the ethical acceptability of physicians receiving gifts from drug companies. Professional guidelines recognize industry gifts as a conflict of interest and establish thresholds prohibiting the exchange of large gifts while expressly allowing for the exchange of small gifts such as pens, note pads, and coffee. Considerable evidence from the social sciences suggests that gifts of negligible value can influence the behavior of the recipient in ways the recipient does not always realize. Policies and guidelines that rely on arbitrary value limits for gift-giving or receipt should be reevaluated. |
| | |
Authors:
|
Dana Katz; Arthur L Caplan; Jon F Merz |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The American journal of bioethics : AJOB Volume: 10 ISSN: 1536-0075 ISO Abbreviation: Am J Bioeth Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-14 Completed Date: 2010-11-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100898738 Medline TA: Am J Bioeth Country: England |
Other Details:
|
Languages: eng Pagination: 11-7 Citation Subset: E; IM |
Affiliation:
|
University of Pennsylvania, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
American Medical Association Conflict of Interest* / economics, legislation & jurisprudence Cooperative Behavior Drug Industry / ethics* Gift Giving / ethics* Guidelines as Topic* Humans Information Dissemination / ethics* Interpersonal Relations* Physicians / ethics* Public Policy Social Values* United States |
| Comments/Corrections | |
Comment In:
|
Am J Bioeth. 2010 Oct;10(10):18
[PMID:
20945263
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: An Open Letter to Institutional Review Boards Considering Northfield Laboratories' PolyHeme® Trial.
Next Document: PhRMA's Code on Interactions With Healthcare Professionals.